23 October 2024: Articles
Postpartum Hemorrhage Management with Bakri Balloon: Investigating Retained Placenta Risk
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Unexpected drug reaction, Educational Purpose (only if useful for a systematic review or synthesis)
Shohei TanabeDOI: 10.12659/AJCR.945672
Am J Case Rep 2024; 25:e945672
Abstract
BACKGROUND: Retained products of conception (RPOC) is a rare complication following second-trimester delivery or pregnancy termination, often leading to significant hemorrhage. Diagnosed via ultrasound or CT, RPOC requires surgical intervention based on endometrial thickness. Risk factors include second-trimester abortion and use of placental forceps. We report a case of RPOC diagnosed 1 month postpartum after using a Bakri balloon for atonic hemorrhage during full-term delivery.
CASE REPORT: The patient, a 32-year-old woman with a history of 4 pregnancies and 3 births, conceived via frozen embryo transfer, which was her first infertility treatment. At 36 weeks of gestation, blood tests revealed a hemoglobin level of 10.4 g/dl. She delivered vaginally at 38 weeks 2 days, but postpartum uterine contractions were poor, leading to significant bleeding. Oxytocin administration and uterine massage failed to improve contractions, so a Bakri balloon was inserted. The total blood loss was 2263 cc, and 6 units of RBCs were transfused. The next day, the Bakri balloon was removed, and ultrasonography confirmed the absence of retained placenta before discharge on postpartum day 5. However, at her 1-month checkup, a retained placenta was diagnosed, requiring further intervention. The patient declined follow-up.
CONCLUSIONS: We encountered a case of RPOC 1 month after using a Bakri balloon. Although the relationship between the 2 remains unclear, it may be preferable to avoid such treatment in the future.
Keywords: Hemorrhage, Placenta, Retained, Balloon Occlusion, Humans, Female, adult, Pregnancy, Postpartum Hemorrhage, Uterine Balloon Tamponade
Introduction
Retained products of conception (RPOC) is a rare complication that occurs after second-trimester delivery or pregnancy termination and often causes massive hemorrhage [1]. RPOC is diagnosed by ultrasonography or computed tomography (CT), and the presence of chorionic villi is confirmed by histological examination [2]. Symptoms in most women include genital bleeding, and the need for surgical intervention is determined by the thickness of the endometrium on ultrasound [3]. Abortion in the second trimester of pregnancy and use of placental forceps during delivery are risk factors for RPOC [4]. The Bakri balloon is used for treating postpartum atonic hemorrhage that does not respond to drugs [5]. Here, we report a case in which RPOC was diagnosed at the 1-month postpartum ultrasound examination after the use of a Bakri balloon owing to flaccid hemorrhage during full-term delivery.
Case Report
The patient was a 32-year-old woman with no relevant medical history. Her pregnancy history included 4 pregnancies and 3 births. Pregnancy was established by frozen embryo transfer. This was the first treatment for infertility in our patient. Thereafter, the pregnancy was managed at our hospital. Blood tests performed at 36 weeks of gestation revealed a hemoglobin level of 10.4 g/dl. Labor began at 38 weeks 2 days of gestation, and the baby was delivered vaginally on the same day. The placenta was delivered smoothly. After delivery of the placenta, uterine contractions were poor and bleeding persisted. Continuous administration of oxytocin and uterine massage did not improve uterine contractions. Ultrasonography confirmed the absence of placental remnants in the uterus, and a Bakri balloon was inserted into the uterus to stop the bleeding. Ultrasonography revealed that the Bakri balloon was retained in the uterus. Thereafter, the bleeding stopped. No anesthesia was administered during the procedure. The total bleeding volume was 2263 cc. Blood tests revealed a decreased Hb level of 5.3 g/dl, and 6 units of RBC were transfused. The next morning, the Bakri balloon was removed, and hemostasis was confirmed. Blood tests showed improvement to Hb 9.2 g/dl. Transvaginal ultrasonography performed on the fourth postpartum day revealed no specific complications (Figure 1), and the patient was discharged on postpartum day 5. At the 1-month postpartum checkup, 33 days after delivery, the patient had a small amount of genital bleeding. Transvaginal ultrasonography revealed multiple pulsatile vascular shadows in the uterus (Figure 2). Contrast-enhanced CT revealed mass staining of the uterine body from the arterial phase to the equilibrium phase, and a residual placenta was suspected (Figure 3). The following day, the patient was referred to a high-level facility capable of providing endovascular treatment. During a gynecological examination at the higher-level institution, the placenta was almost completely ejected from the uterus; therefore, it was removed vaginally. Heavy bleeding occurred, and a balloon catheter (not a Bakri balloon) was inserted into the uterus to stop the bleeding. The balloon catheter was removed after several minutes, hemostasis was confirmed, and the procedure was completed. The patient was scheduled for follow-up at an outpatient clinic but refused; therefore, the visit was canceled.
Discussion
In the present case, a Bakri balloon was used for postpartum hemorrhage due to contraction failure during full-term delivery, and RPOC was diagnosed 1 month later.
Uterine balloon tamponade devices are commonly used to manage postpartum flaccid hemorrhage, and the Bakri balloon is usually a safe, simple, and effective method for treating excessive postpartum bleeding [6]; however, risks such as infection have also been reported [7]. Placental adhesions are a factor in Bakri balloon failure [8]. However, the risk of RPOC due to Bakri balloon use has not been reported.
RPOC often develops after abortion, and risk factors in patients who have undergone manual vacuum aspiration have been discussed [9]. Placental forceps have also been reported as a risk factor for RPOC [4]. Bakri balloon use may also be associated with RPOC.
However, excessive postpartum hemorrhage is a risk factor for RPOC [10]; therefore, it remains unclear whether the Bakri balloon definitively can cause RPOC. Further studies with larger sample sizes are warranted to determine the general safety of the Bakri balloon for postpartum hemorrhage.
Conclusions
We encountered a case of RPOC 1 month after using a Bakri balloon. Although the relationship between the 2 remains unclear, it may be preferable to avoid such cases in the future.
Figures
References:
1.. Thangarajah F, Brunner M, Pahmeyer C, Predictors of postpartum retained products at conception: In Vivo, 2019; 33; 469-72
2.. Sellmyer MA, Desser TS, Maturen KE, Physiologic, histologic, and imaging features of retained products of conception: Radiographics, 2013; 33; 781-96
3.. Kamaya A, Krishnarao PM, Nayak N, Clinical and imaging predictors for management of retained products of conception: Abdom Radiol (NY), 2016; 41; 2429-34
4.. Noguchi T, Shiro M, Nanjo S, Risk factors for retained products of conception after miscarriage or termination with gemeprost in the second trimester of pregnancy: A retrospective case-control study in the Japanese population: J Obstet Gynaecol, 2022; 42; 501-4
5.. Doumouchtsis SK, Papageorghiou AT, Vernier E, Arulkumaran S, Management of postpartum hemorrhage by uterine balloon tamponade: Prospective evaluation of effectiveness: Acta Obstet Gynecol Scand, 2008; 87; 849-55
6.. Brown H, Okeyo S, Mabeya H, The Bakri tamponade balloon as an adjunct treatment for refractory postpartum hemorrhage: Int J Gynecol Obstet, 2016; 135; 276-80
7.. Overton E, D’Alton M, Goffman D, Intrauterine devices in the management of postpartum hemorrhage: Am J Obstet Gynecol, 2024; 230; S1076-88
8.. Xu TY, Fu Q, Risk factors for Bakri balloon tamponade failure in the management of postpartum hemorrhage: Int J Gynaecol Obstet, 2023; 160; 685-90
9.. Inal MM, Yildirim Y, Ertopcu K, The predictors of retained products of conception following first-trimester pregnancy termination with manual vacuum aspiration: Eur J Contracept Reprod Health Care, 2006; 11; 98-103
10.. Rottenstreich M, Atia O, Greifner N, Prospective evaluation of clinical characteristics and maternal outcomes of women with pathologically confirmed postpartum retained placental fragments: J Matern Fetal Neonatal Med, 2022; 35; 7322-29
Figures
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






